Gender-specific, multi-level determinants of outcomes of antihypertensive treatment: A sub-analysis of the Belgian PREVIEW study

Journal of Human Hypertension

Volumn 25, Issue 6, 2011, Pages 372-382

  MacDonald, K ^a   Lee, C S ^a,b   Chen, H C ^b,c   Ko, M L ^b   Fidel, G E ^d   Brie H ^d   Hermans, C ^d   Vancayzeele, S ^d   Reel, S ^b   Van Der Niepen, P ^e   Abraham, I ^a,b  

^a Matrix45 ^*  (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d Novartis Pharma   (Belgium)

^e UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

effectiveness; gender; valsartan

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE PLUS HYDROCHLOROTHIAZIDE PLUS VALSARTAN; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; VALSARTAN;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD PRESSURE REGULATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIURETIC THERAPY; FEMALE; GENERAL PRACTITIONER; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PHYSICIAN; PRACTICE GUIDELINE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BELGIUM; BLOOD PRESSURE; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED; PATIENTS; PHYSICIANS; PROSPECTIVE STUDIES; SEX CHARACTERISTICS; TETRAZOLES; TREATMENT FAILURE; TREATMENT OUTCOME; VALINE;

EID: 79956119255     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2010.71     Document Type: Article

References (35)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365(9455): 217-223. (Pubitemid 40138015)
2. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289(18): 2363-2369. (Pubitemid 37430168)
3. Kannel WB. Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardiol 2000; 85(2): 251-255. (Pubitemid 30026111)
4. Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens 2006; 24(3): 423-430. (Pubitemid 43261901)
5. Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet 2008; 371(9623): 1513-1518. (Pubitemid 351626187)
6. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345(18): 1291-1297.
7. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289(19): 2560-2572. (Pubitemid 37430158)
8. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21(6): 1011-1053.
9. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. ESH-ESC task force on the management of arterial hypertension. 2007 ESH-ESC practice guidelines for the management of arterial hypertension. J Hypertens 2007; 25(9): 1751-1762. (Pubitemid 47356612)
10. Whitworth JA. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21(11): 1983-1992. (Pubitemid 38296854)
11. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B et al. Inadequate management ofblood pressure in a hypertensive population. N Engl J Med 1998; 339(27): 1957-1963. (Pubitemid 29024127)
12. Fagard RH, Van Den Enden M, Leeman M, Warling X. Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium. J Hypertens 2002; 20(7): 1297-1302. (Pubitemid 34925673)
13. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290(2): 199-206. (Pubitemid 37430058)
14. Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA 2005; 294(4): 466-472. (Pubitemid 41124179)
15. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007; 49(1): 69-75. (Pubitemid 46360343)
16. Van der Niepen P, Giot C, van de Borne P. Prevalence of isolated uncontrolled systolic blood pressure among treated hypertensive patients in primary care in Belgium: results of the I-inSYST survey. J Hypertens 2008; 26(10): 2057-2063.
17. Degli Esposti E, Di Martino M, Sturani A, Russo P, Dradi C, Falcinelli S et al. Risk factors for uncontrolled hypertension in Italy. J Hum Hypertens 2004; 18(3): 207-213. (Pubitemid 38425773)
18. Oliveria SA, Lapuerta P, McCarthy BD, L'Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 2002; 162(4): 413-420. (Pubitemid 34150642)
19. Okonofua EC, Simpson KN, Jesri A, Rehman SU, Durkalski VL, Egan BM. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension 2006; 47(3): 345-351. (Pubitemid 43740273)
20. Gasse C, Hense HW, Stieber J, Doring A, Liese AD, Keil U. Assessing hypertension management in the community: trends of prevalence, detection, treatment, and control of hypertension in the MONICA Project, Augsburg 1984-1995. J Hum Hypertens 2001; 15(1): 27-36. (Pubitemid 32106765)
21. Ostchega Y, Dillon CF, Hughes JP, Carroll M, Yoon S. Trends in hypertension prevalence, awareness, treatment, and control in older US adults: data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc 2007; 55(7): 1056-1065. (Pubitemid 47024610)
22. Jokisalo E, Kumpusalo E, Enlund H, Halonen P, Takala J. Factors related to non-compliance with antihypertensive drug therapy. J Hum Hypertens 2002; 16(8): 577-583. (Pubitemid 35021365)
23. Van Wijk BL, Klungel OH, Heerdink ER, de Boer A. Rate and determinants of 10-year persistence with ntihypertensive drugs. J Hypertens 2005; 23(11): 2101-2107. (Pubitemid 41830407)
24. Bailey KR, Grossardt BR, Graves JW. Novel use of Kaplan-Meier methods to explain age and genderdifferences in hypertension control rates. Hypertension 2008; 51(4): 841-847. (Pubitemid 351654693)
25. Banegas JR, Segura J, de la Sierra A, Gorostidi M, Rodriguez-Artalejo F, Sobrino J et al. Gender differences in office and ambulatory control of hypertension. Am J Med 2008; 121(12): 1078-1084.
26. Thoenes M, Neuberger HR, Volpe M, Khan BV, Kirch W, Bohm M. Antihypertensive drug therapy and blood pressure control in men and women: an international perspective. J Hum Hypertens 2010; 24: 336-344.
27. Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part 1: estimates of blood pressure levels. J Hypertens 2006; 24(3): 413-422. (Pubitemid 43261900)
28. Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension 2001; 37(5): 1199-1208. (Pubitemid 34163570)
29. Van der Niepen P, Woestenburg A, Brie H, Vancayzeele S, MacDonald K, Denhaerynck K et al. Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study). Ann Pharmacother 2009; 43(5): 849-861.
30. Abraham I, Lee CS, Song M, Vancayzeele S, Brie H, Hermans C et al. 'Later, lazier, and unluckier': a heuristic profile of high vulnerability is an independent predictor of uncontrolled blood pressure (the PREVIEW study). Int J Gen Med 2010; 3: 163-166.
31. Verbeke G, Molenberghs G. Linear Mixed Models for Longitudinal Data. Springer-Verlag: New York, NY, 2000.
32. Choudhry NK, Fletcher RH, Soumerai SB. Systematic review: the relationship between clinical experience and quality of health care. Ann Intern Med 2005; 142(4): 260-273. (Pubitemid 40216243)
33. McLean DL, Simpson SH, McAlister FA, Tsuyuki RT. Treatment and blood pressure control in 47,964 people with diabetes and hypertension: a systematic review of observational studies. Can J Cardiol 2006; 22(10): 855-860. (Pubitemid 44488023)
34. Messerli FH, Williams B, Ritz E. Essential hypertension. Lancet 2007; 370(9587): 591-603. (Pubitemid 47247855)
35. Journath G, Hellenius ML, Petersson U, Theobald H, Nilsson PM. Sex differences in risk factor control of treated hypertensives: a national primary healthcarebased study in Sweden. Eur J Cardiovasc Prev Rehabil 2008; 15(3): 258-262.